Charles River Laboratories International Inc (CRL) Q3 2025 Earnings Call Highlights: Strategic ...

Despite a slight revenue decline, CRL focuses on strategic initiatives and cost savings to drive long-term growth and ...
Zacks Investment Research on MSN

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Charles River Laboratories (CRL) is expected to deliver a year-over-year decline in earnings on lower revenues when it ...
StockStory.org on MSN

Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today

What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after ...

Charles River Beat Expectations But Why Is The Stock Falling?

Charles River stock dips as Q3 revenue slips, EPS beats estimates, and company raises 2025 outlook with cost cuts and $1 ...

Charles River: Mixed Q3 As Strategic Review Disappoints

Charles River Laboratories International, Inc. remains a Hold as strategic review yields minimal change and a sale is ...

Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue

Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.

Evercore ISI Sticks to Its Buy Rating for Charles River Labs (CRL)

Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.
Zacks.com on MSN

Here's How Charles River Stock Is Placed Ahead of Q3 Earnings

Charles River Laboratories International, Inc. CRL is scheduled to report third-quarter 2025 results on Nov. 5, before the ...
Zacks.com on MSN

Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates

Charles River (CRL) delivered earnings and revenue surprises of +4.74% and +2.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?